月経前症候群および月経ヘルスサプリメントの世界市場

月経前症候群および月経ヘルスサプリメントの世界市場は2030年までに246億米ドルに到達

2024年に200億米ドルと推定される月経前症候群および月経ヘルスサプリメントの世界市場は、2024年から2030年にかけてCAGR 3.6%で成長し、2030年には246億米ドルに達すると予測されます。本レポートで分析したセグメントの一つである複合栄養補助食品は、CAGR 2.9%を記録し、分析期間終了時には152億米ドルに達すると予測されます。単一栄養サプリメントセグメントの成長率は、分析期間中CAGR 4.6%と推定されます。

米国市場は54億米ドルと推定、中国はCAGR6.5%で成長予測

米国の月経前症候群および月経ヘルスサプリメント市場は、2024年には54億米ドルになると推定されます。世界第2位の経済大国である中国は、2030年までに49億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは6.5%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.5％と2.7％と予測されています。欧州では、ドイツがCAGR 2.0%で成長すると予測されています。

世界の月経前症候群および月経ヘルスサプリメント市場- 主要動向と促進要因まとめ

栄養補助食品の革新は女性の月経健康管理をどのように再構築しているか？

月経前症候群（PMS）および月経健康サプリメント市場は、ホルモンバランス、炎症コントロール、感情的幸福をターゲットとする特殊な栄養補助食品の台頭によって推進され、大きな変化を遂げつつあります。最近の製剤は、チェストベリーエキス（ビテックス・アグヌス-カストゥス）、マグネシウム、ビタミンB6、カルシウム、月見草オイル、オメガ3脂肪酸など、気分の落ち込み、けいれん、腹部膨満感、疲労などの症状を緩和することで知られる、臨床的に研究された成分を中心に作られることが多くなっています。これらの生物活性化合物は、神経伝達物質の調節、プロスタグランジンの調節、内分泌系のバランスをサポートし、単に症状を隠すのではなく、PMSの根本的なメカニズムに直接作用します。

最近の技術革新では、アダプトゲン（アシュワガンダ、ロディオラ・ロゼアなど）、植物性エストロゲン（大豆イソフラボンなど）、抗炎症ハーブ（ウコン、ショウガなど）を組み合わせた相乗効果のあるブレンドにより、月経周期のさまざまな段階に合わせたホリスティックなサプリメント・ソリューションを作り出しています。タイムリリースカプセル、舌下スプレー、機能性グミは、バイオアベイラビリティとユーザーのコンプライアンスを向上させ、一般的な送達形式になってきています。さらに、AI対応のサプリメント・パーソナライゼーション・プラットフォームが登場し、ホルモン・プロファイリング、ライフスタイル、食事に基づいてアルゴリズムが生成した推奨品を提供しています。このような進歩により、サプリメントは単に症状を管理するだけでなく、女性の生殖に関する健康という大きな展望の中で、長期的な健康を最適化するものとして位置づけられています。

サプリメントは、従来の市販の緩和製品を超えて、どこで地歩を固めているのか？

PMSや月経の健康のためのサプリメントは、薬局や小売チェーンの枠を超えて、様々な新しい領域で人気を集めています。デジタルヘルス分野では、月経追跡アプリを提供するフェムテック・プラットフォームが、サプリメントの定期購入とパーソナライズされた周期に関する洞察を統合しています。消費者直販（DTC）ブランドは、サプリメント、ハーブティー、プロバイオティクスを組み合わせた月経健康キットを、定期購入ベースのウェルネス・エコシステムの一部としてパッケージ化しています。これらの商品は、利便性、プライバシー、透明性を求める消費者、特に自然な代替品やハイテクを駆使した健康ソリューションに惹かれる若年層をターゲットにしています。

職場や大学も流通拠点として台頭してきており、企業のウェルネス・プログラムや学生の健康イニシアチブが、より広範な月経平等キャンペーンの一環としてサプリメントへのアクセスを提供しています。これと並行して、不妊治療クリニックや婦人科センターでは、周期不順、多嚢胞性卵巣症候群（PCOS）、黄体期不全を経験する患者のための統合的治療計画にサプリメントを取り入れています。スポーツやアクティブなライフスタイルの分野では、アスリートやフィットネスに熱心な女性が、パフォーマンスの安定性を維持するために、周期を調整するサプリメントを利用しています。このような機関、デジタル、ライフスタイル主導のチャネルへの拡大は、サプリメントの認知度を高め、より広い予防健康の枠組みの中にサプリメントを組み込んでいます。

消費者の嗜好や健康意識の変化は、製剤やブランディングにどのような影響を与えているか？

現代の消費者、特にミレニアル世代とZ世代は、クリーンラベル、ビーガン、アレルゲンフリー、倫理的に調達された原材料を要求することで、月経とサプリメントの使用に関する期待を再定義しています。サプリメントメーカーは、こうした嗜好にアピールするため、非遺伝子組み換え植物、砂糖ゼロ、プラスチックフリーのパッケージ、第三者機関によるテストをますます強調するようになっています。臨床検証やデジタルトレーサビリティに裏打ちされたラベル表示の透明性は、市場で成功するための必須条件となりつつあります。人気のポジショニング戦略は、「ホルモンフリーの救済」、「根本的な原因のサポート」、「サイクルシンク」に焦点を当て、治療からボディリテラシーとエンパワーメントへと物語をシフトさせています。

ソーシャルメディアとインフルエンサーマーケティングは、認識を形成し製品発見を促進する上で重要な役割を果たしています。月経科学、ボディ・ポジティビティ、ホリスティック・ウェルネスを強調する教育キャンペーンは、月経の文化的非物質化に寄与しており、それによって毎月のサポート儀式への需要を促進しています。さらに、トランスジェンダーやノンバイナリーである月経者に対応する包括的ブランディングの台頭は、月経健康サプリメントの利用者を拡大しています。多様な世界市場に浸透するために、多言語表示、文化的調整、地域特有の製品処方が用いられています。科学的信頼性、倫理的製造、包括的コミュニケーションの融合は、月経健康サプリメントの処方、販売、消費のあり方を再定義しています。

月経健康サプリメント市場の世界的成長を牽引している力は何か？

世界のPMSと月経健康サプリメント市場の成長は、女性の健康問題に対する意識の高まり、リプロダクティブ・ウェルネス情報へのアクセスの増加、非医薬品的介入に対する需要の高まりが原動力となっています。PMSの蔓延は世界的に月経のある人の70％以上に影響し、その症状は軽度の不快感から重篤な気分障害や疼痛障害に及ぶため、女性は従来の鎮痛剤やホルモン治療に代わる、より安全で自然な代替品を積極的に求めています。この需要は、特に都市部や、健康管理に積極的で、教育を受け、デジタルに接続された人々の間で強いです。

月経衛生教育や月経衛生管理（MHM）を支援する政府や非政府の取り組みは、間接的に栄養格差やホルモンの健康に対する意識を高めています。これと並行して、eコマース・プラットフォームや健康に焦点を当てたマーケットプレースは、ニッチでプレミアムなサプリメント・ブランドへの世界のアクセスを可能にしています。月経の健康と、腸の健康、心の健康、ホルモンの調和など、より広範なウェルネス動向との交差は、より広範な消費者ニーズに対応するカテゴリー横断的な製品イノベーションを促進しています。

フェムテックや女性中心の健康ベンチャーへの投資意欲は、サプリメント企業の研究開発とスケーリング能力を促進し、より迅速な製品開発と世界の拡大を可能にしています。サプリメントブランドとヘルスケア専門家との戦略的パートナーシップは、医療受容性と消費者の信頼を高めています。ライフスタイル・ウェルネス・レジメンへの統合が進み、栄養補助食品に対する規制当局のサポートが高まり、月経の文化的正常化が進む中、PMSおよび月経健康サプリメント市場は今後数年間、先進地域と新興地域の両方で一貫した2桁成長が見込まれます。

セグメント

製品タイプ（複合栄養補助食品、単一栄養補助食品）、適応症（更年期障害適応症、PMS適応症）、形態（カプセル／錠剤形態、粉末形態、ソフトジェル形態、その他形態）、エンドユーザー（薬局／ドラッグストアエンドユーザー、オンライン流通エンドユーザー、直接流通エンドユーザー、その他エンドユーザー）

調査対象企業の例

• Amway
• Bayer AG
• Bonafide Health, LLC
• Eu Natural
• FLO Living
• Garden of Life（Nestle Health Science）
• GNC Holdings, LLC
• Health & Her
• Himalaya Wellness Company
• HUM Nutrition Inc.
• i-Health, Inc.（DSM-Firmenich）
• Kora Organics
• MaryRuth Organics
• MegaFood（FoodState Inc.）
• Nature's Bounty Co.
• New Chapter, Inc.
• Nutrafol
• Olly PBC
• Pink Stork
• Sakara Life

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Premenstrual Syndrome and Menstrual Health Supplements Market to Reach US$24.6 Billion by 2030

The global market for Premenstrual Syndrome and Menstrual Health Supplements estimated at US$20.0 Billion in the year 2024, is expected to reach US$24.6 Billion by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. Combined Nutritional Supplements, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$15.2 Billion by the end of the analysis period. Growth in the Single Nutritional Supplements segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.4 Billion While China is Forecast to Grow at 6.5% CAGR

The Premenstrual Syndrome and Menstrual Health Supplements market in the U.S. is estimated at US$5.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.9 Billion by the year 2030 trailing a CAGR of 6.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 2.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.0% CAGR.

Global Premenstrual Syndrome and Menstrual Health Supplements Market - Key Trends & Drivers Summarized

How Are Nutraceutical Innovations Reshaping Menstrual Health Management for Women?

The premenstrual syndrome (PMS) and menstrual health supplements market is undergoing a significant shift, propelled by the rise of specialized nutraceuticals targeting hormonal balance, inflammation control, and emotional well-being. Modern formulations are increasingly built around clinically studied ingredients such as chasteberry extract (Vitex agnus-castus), magnesium, vitamin B6, calcium, evening primrose oil, and omega-3 fatty acids-known to alleviate symptoms such as mood swings, cramps, bloating, and fatigue. These bioactive compounds support neurotransmitter regulation, prostaglandin modulation, and endocrine system balance, directly addressing underlying mechanisms of PMS rather than merely masking symptoms.

Recent innovations involve synergistic blends combining adaptogens (e.g., ashwagandha, Rhodiola rosea), phytoestrogens (e.g., soy isoflavones), and anti-inflammatory herbs (e.g., turmeric, ginger) to create holistic supplement solutions tailored for different phases of the menstrual cycle. Time-release capsules, sublingual sprays, and functional gummies are becoming popular delivery formats, enhancing bioavailability and user compliance. Additionally, AI-enabled supplement personalization platforms are emerging, offering algorithm-generated recommendations based on hormonal profiling, lifestyle, and diet. These advances are positioning supplements not just as symptom managers but as long-term health optimizers within the larger landscape of female reproductive wellness.

Where Are Supplements Gaining Ground Beyond Traditional Over-the-Counter Relief Products?

Supplements for PMS and menstrual health are gaining traction across a variety of new domains beyond pharmacies and retail chains. In the digital health space, femtech platforms offering menstrual tracking apps are integrating supplement subscriptions with personalized cycle insights. Direct-to-consumer (DTC) brands are packaging menstrual health kits that combine supplements, herbal teas, and probiotics as part of subscription-based wellness ecosystems. These offerings target consumers seeking convenience, privacy, and transparency-particularly younger demographics drawn to natural alternatives and tech-enabled health solutions.

Workplaces and universities are also emerging as distribution points, where corporate wellness programs and student health initiatives provide supplement access as part of broader menstrual equity campaigns. In parallel, fertility clinics and gynecology centers are incorporating supplements into integrative treatment plans for patients experiencing irregular cycles, polycystic ovarian syndrome (PCOS), and luteal phase defects. In sports and active lifestyles segments, athletes and fitness-focused women are turning to cycle-regulating supplements to maintain performance consistency. This expansion into institutional, digital, and lifestyle-driven channels is increasing supplement visibility and embedding it within a wider preventive health framework.

How Are Changing Consumer Preferences and Health Awareness Impacting Formulation and Branding?

Modern consumers-especially millennials and Gen Z-are redefining expectations around menstruation and supplement use by demanding clean-label, vegan, allergen-free, and ethically sourced ingredients. Supplement manufacturers are increasingly emphasizing non-GMO botanicals, zero added sugar, plastic-free packaging, and third-party testing to appeal to these preferences. Transparency in labeling, backed by clinical validation and digital traceability, is becoming a prerequisite for market success. Popular positioning strategies focus on "hormone-free relief," "root-cause support," and “cycle syncing,” shifting the narrative from disorder treatment to body literacy and empowerment.

Social media and influencer marketing are playing a critical role in shaping perceptions and driving product discovery. Educational campaigns emphasizing menstrual science, body positivity, and holistic wellness are contributing to a cultural destigmatization of menstruation-thereby fostering demand for monthly support rituals. Furthermore, the rise of inclusive branding that addresses transgender and non-binary menstruators is expanding the audience for menstrual health supplements. Multilingual labeling, cultural tailoring, and region-specific product formulations are being used to penetrate diverse global markets. This fusion of scientific credibility, ethical manufacturing, and inclusive communication is redefining the way menstrual health supplements are formulated, marketed, and consumed.

What Forces Are Driving the Global Growth of the Menstrual Health Supplements Market?

The growth in the global PMS and menstrual health supplements market is driven by rising awareness of women’s health issues, increased access to reproductive wellness information, and growing demand for non-pharmaceutical interventions. As the prevalence of PMS affects over 70% of menstruating individuals globally-with symptoms ranging from mild discomfort to severe mood and pain disorders-women are actively seeking safer, natural alternatives to conventional analgesics and hormonal treatments. This demand is particularly strong in urban areas and among educated, digitally connected populations who are proactive in health management.

Government and non-government initiatives supporting menstrual health education and menstrual hygiene management (MHM) are indirectly boosting awareness of nutritional gaps and hormonal health. In parallel, e-commerce platforms and health-focused marketplaces are enabling global access to niche and premium supplement brands. The intersection of menstrual health with broader wellness trends-such as gut health, mental wellness, and hormonal harmony-is driving cross-category product innovations that cater to a wider spectrum of consumer needs.

Investment interest in femtech and women-centric health ventures is fueling R&D and scaling capabilities for supplement companies, enabling faster product development and global expansion. Strategic partnerships between supplement brands and healthcare professionals are enhancing medical acceptance and consumer trust. With increasing integration into lifestyle wellness regimens, rising regulatory support for dietary supplements, and growing cultural normalization of menstruation, the PMS and menstrual health supplements market is expected to witness consistent, double-digit growth across both developed and emerging regions in the coming years.

SCOPE OF STUDY:

The report analyzes the Premenstrual Syndrome and Menstrual Health Supplements market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Combined Nutritional Supplements, Single Nutritional Supplements); Indication (Perimenopause Indication, PMS Indication); Form (Capsules / Tablets Form, Powder Form, Softgel Form, Other Forms); End-Use (Pharmacies / Drug Stores End-Use, Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• Amway
• Bayer AG
• Bonafide Health, LLC
• Eu Natural
• FLO Living
• Garden of Life (Nestle Health Science)
• GNC Holdings, LLC
• Health & Her
• Himalaya Wellness Company
• HUM Nutrition Inc.
• i-Health, Inc. (DSM-Firmenich)
• Kora Organics
• MaryRuth Organics
• MegaFood (FoodState Inc.)
• Nature's Bounty Co.
• New Chapter, Inc.
• Nutrafol
• Olly PBC
• Pink Stork
• Sakara Life

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Premenstrual Syndrome and Menstrual Health Supplements - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Growing Awareness of Menstrual Wellness and Hormonal Health Drives Adoption of Targeted Supplements
  • Rising Female Workforce Participation Expands Addressable Market for Mood and Pain Relief Products
  • Shift Toward Natural and Botanical Formulations Throws the Spotlight on Herbal Menstrual Supplements
  • Expansion of Direct-to-Consumer Brands Strengthens Visibility of PMS and Menstrual Health Products
  • Technological Advancements in Nutraceutical Delivery Systems Enhance Bioavailability and Compliance
  • OEM Collaborations With Gynecologists and Wellness Experts Promote Clinical Validation of Supplements
  • Increasing Demand for Non-Pharmaceutical Alternatives Supports Preventive Supplement Adoption
  • Personalization Trends in Women's Health Propel Demand for Hormone-Specific Nutrient Combinations
  • Growth in E-Commerce and Subscription-Based Wellness Models Enhances Product Accessibility
  • Influencer and Social Media Advocacy Accelerates Market Education and Product Discovery
  • Regulatory Support for OTC Nutraceuticals in Menstrual Health Strengthens Global Product Expansion
  • Integration of Supplements Into Digital Health and Cycle-Tracking Apps Boosts Usage and Engagement
  • Demand for Clean-Label, Non-GMO, and Allergen-Free Formulations Supports Premium Segment Growth
  • Surge in Consumer Interest in Adaptogens and Ayurvedic Remedies Drives Alternative Medicine Offerings
  • Focus on Reducing Reliance on NSAIDs and Hormonal Drugs Fuels Preventive Supplement Trends
  • Increased Investment in R&D Around PMS Symptom Clusters Enhances Product Differentiation
  • Retail Pharmacy and Wellness Chain Expansion Improves Product Placement and Point-of-Care Sales
  • Cross-Selling With Multivitamins, Skin, and Mood Supplements Strengthens Portfolio Synergies
  • Rise in Mental Health Awareness Encourages Integration of PMS and Mood Support Formulations
  • Menstrual Equity and Inclusivity Movements Promote Diverse and Culturally Adapted Supplement Offerings
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Premenstrual Syndrome and Menstrual Health Supplements Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Combined Nutritional Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Combined Nutritional Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Combined Nutritional Supplements by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Single Nutritional Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Single Nutritional Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Single Nutritional Supplements by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Online Distribution Channel End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Online Distribution Channel End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Online Distribution Channel End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Direct Distribution Channel End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Direct Distribution Channel End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Direct Distribution Channel End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Pharmacies / Drug Stores End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Pharmacies / Drug Stores End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Pharmacies / Drug Stores End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Perimenopause Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Perimenopause Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Perimenopause Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for PMS Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for PMS Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for PMS Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Capsules / Tablets Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Capsules / Tablets Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Capsules / Tablets Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Powder Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Powder Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Powder Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Softgel Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Softgel Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Softgel Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Other Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Other Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Other Forms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: USA 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: USA 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: USA 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: USA 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: Canada 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: Canada 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: Canada 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: Canada 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
• JAPAN
  • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: Japan 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: Japan 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: Japan 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
  • TABLE 74: Japan Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: Japan 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
• CHINA
  • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 77: China Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: China 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: China 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
  • TABLE 83: China Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: China 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
  • TABLE 86: China Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: China Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: China 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
• EUROPE
  • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: Europe 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: Europe 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: Europe 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: Europe 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
  • TABLE 101: Europe Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Europe Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Europe 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
• FRANCE
  • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 104: France Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: France Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: France 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
  • TABLE 107: France Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: France Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: France 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
  • TABLE 110: France Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: France Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: France 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
  • TABLE 113: France Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: France Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: France 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
• GERMANY
  • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 116: Germany Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Germany Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: Germany 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
  • TABLE 119: Germany Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Germany Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: Germany 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
  • TABLE 122: Germany Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Germany Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: Germany 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
  • TABLE 125: Germany Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Germany Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: Germany 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 128: Italy Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Italy Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: Italy 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
  • TABLE 131: Italy Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Italy Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Italy 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
  • TABLE 134: Italy Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Italy Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Italy 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
  • TABLE 137: Italy Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Italy Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Italy 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 140: UK Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: UK Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: UK 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
  • TABLE 143: UK Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: UK Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: UK 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
  • TABLE 146: UK Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: UK Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: UK 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
  • TABLE 149: UK Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: UK Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: UK 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 152: Spain Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Spain Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: Spain 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
  • TABLE 155: Spain Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Spain Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: Spain 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
  • TABLE 158: Spain Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Spain Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: Spain 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
  • TABLE 161: Spain Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Spain Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Spain 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 164: Russia Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Russia Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: Russia 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
  • TABLE 167: Russia Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Russia Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: Russia 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
  • TABLE 170: Russia Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Russia Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: Russia 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
  • TABLE 173: Russia Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Russia Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: Russia 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Rest of Europe Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: Rest of Europe 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
  • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Europe Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: Rest of Europe 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
  • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Europe Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: Rest of Europe 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
  • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Europe Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: Rest of Europe 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 189: Asia-Pacific Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: Asia-Pacific 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Asia-Pacific Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: Asia-Pacific 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
  • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Asia-Pacific Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Asia-Pacific 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 203: Australia Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Australia Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Australia 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
  • TABLE 206: Australia Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Australia Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Australia 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
  • TABLE 209: Australia Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Australia Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Australia 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
  • TABLE 212: Australia Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Australia Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Australia 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
• INDIA
  • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 215: India Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: India Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: India 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
  • TABLE 218: India Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: India Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: India 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
  • TABLE 221: India Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: India Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: India 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
  • TABLE 224: India Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: India Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: India 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 227: South Korea Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: South Korea Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: South Korea 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
  • TABLE 230: South Korea Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: South Korea Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: South Korea 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
  • TABLE 233: South Korea Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: South Korea Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: South Korea 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
  • TABLE 236: South Korea Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: South Korea Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: South Korea 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Asia-Pacific Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: Rest of Asia-Pacific 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
  • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Asia-Pacific Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: Rest of Asia-Pacific 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
  • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Asia-Pacific Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: Rest of Asia-Pacific 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
  • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Asia-Pacific Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: Rest of Asia-Pacific 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 251: Latin America Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 252: Latin America Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: Latin America 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 254: Latin America Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Latin America Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Latin America 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Latin America 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Latin America 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
  • TABLE 263: Latin America Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Latin America Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Latin America 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 266: Argentina Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Argentina Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Argentina 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
  • TABLE 269: Argentina Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Argentina Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Argentina 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
  • TABLE 272: Argentina Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Argentina Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Argentina 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
  • TABLE 275: Argentina Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Argentina Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: Argentina 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 278: Brazil Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Brazil Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: Brazil 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
  • TABLE 281: Brazil Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Brazil Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: Brazil 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
  • TABLE 284: Brazil Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Brazil Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: Brazil 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
  • TABLE 287: Brazil Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Brazil Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: Brazil 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 290: Mexico Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Mexico Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: Mexico 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
  • TABLE 293: Mexico Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Mexico Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: Mexico 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
  • TABLE 296: Mexico Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Mexico Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: Mexico 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
  • TABLE 299: Mexico Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Mexico Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: Mexico 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Latin America Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 304: Rest of Latin America 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
  • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Latin America Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 307: Rest of Latin America 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
  • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Latin America Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 310: Rest of Latin America 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
  • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Latin America Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 313: Rest of Latin America 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 314: Middle East Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 315: Middle East Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 316: Middle East 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 317: Middle East Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Middle East Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 319: Middle East 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 322: Middle East 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 325: Middle East 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
  • TABLE 326: Middle East Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Middle East Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 328: Middle East 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 329: Iran Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Iran Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 331: Iran 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
  • TABLE 332: Iran Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Iran Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 334: Iran 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
  • TABLE 335: Iran Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Iran Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 337: Iran 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
  • TABLE 338: Iran Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Iran Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 340: Iran 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 341: Israel Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Israel Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 343: Israel 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
  • TABLE 344: Israel Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Israel Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 346: Israel 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
  • TABLE 347: Israel Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Israel Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 349: Israel 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
  • TABLE 350: Israel Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Israel Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 352: Israel 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Saudi Arabia Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 355: Saudi Arabia 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
  • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Saudi Arabia Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 358: Saudi Arabia 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
  • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Saudi Arabia Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 361: Saudi Arabia 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
  • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Saudi Arabia Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 364: Saudi Arabia 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 365: UAE Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: UAE Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 367: UAE 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
  • TABLE 368: UAE Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: UAE Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 370: UAE 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
  • TABLE 371: UAE Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: UAE Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 373: UAE 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
  • TABLE 374: UAE Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: UAE Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 376: UAE 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Rest of Middle East Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 379: Rest of Middle East 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
  • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Rest of Middle East Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 382: Rest of Middle East 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
  • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Rest of Middle East Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 385: Rest of Middle East 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
  • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Rest of Middle East Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 388: Rest of Middle East 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
• AFRICA
  • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 389: Africa Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Africa Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 391: Africa 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
  • TABLE 392: Africa Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Africa Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 394: Africa 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
  • TABLE 395: Africa Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Africa Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 397: Africa 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
  • TABLE 398: Africa Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Africa Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 400: Africa 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030

IV. COMPETITION